2674 related articles for article (PubMed ID: 8658222)
21. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Kim R; Osaki A; Tanabe K; Toge T
Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
Ando N; Ozawa S; Kitajima M; Iizuka T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
[TBL] [Abstract][Full Text] [Related]
24. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
Rosen H
Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
26. [Specific treatment situations in metastatic colorectal cancer].
Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
[TBL] [Abstract][Full Text] [Related]
27. [Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].
Shah MA; Kelsen DP
Chirurg; 2002 Apr; 73(4):325-30. PubMed ID: 12063916
[TBL] [Abstract][Full Text] [Related]
28. [Complementary treatment to surgery of gastric carcinoma: role of adjuvant and neoadjuvant chemotherapy].
Lise M; Nitti D; Marchet A; Tripodi M; Pilati P; Pasetto L
Chir Ital; 1997; 49(3):35-9. PubMed ID: 9612650
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
[TBL] [Abstract][Full Text] [Related]
30. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
31. The role of irradiation as a component of combined modality treatment for gastric cancer.
Gunderson LL; Burch PA; Donohue JH
J Infus Chemother; 1995; 5(3):117-24. PubMed ID: 8528968
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
33. The role of radiation therapy in gastric cancer.
Minsky BD
Semin Oncol; 1996 Jun; 23(3):390-6. PubMed ID: 8658223
[TBL] [Abstract][Full Text] [Related]
34. A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601.
Findlay M; Storey D; Gebski V; Hargreaves C; Cullingford G; Boyer M; Trotter J; Archer S; Davidson A; Johnston P; Yuen J; Dhillon H; Della-Fiorentina S; Richardson G; Truskett P; Goldstein D;
ANZ J Surg; 2007 Apr; 77(4):247-52. PubMed ID: 17388828
[TBL] [Abstract][Full Text] [Related]
35. Gastric cancer in the elderly: an overview.
Saif MW; Makrilia N; Zalonis A; Merikas M; Syrigos K
Eur J Surg Oncol; 2010 Aug; 36(8):709-17. PubMed ID: 20542657
[TBL] [Abstract][Full Text] [Related]
36. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
[TBL] [Abstract][Full Text] [Related]
37. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy].
Watanabe Y
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413
[TBL] [Abstract][Full Text] [Related]
38. Role of adjuvant therapy in colorectal cancer.
Hesketh PJ; Bulger KN
Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
J Clin Oncol; 1996 Jun; 14(6):1818-28. PubMed ID: 8656250
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant therapy for gastrointestinal cancers.
Kelsen D
Oncology (Williston Park); 1993 Sep; 7(9):25-32; discussion 32, 35-6, 41. PubMed ID: 8217529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
